The Autonomic Nervous System (ANS) is a part of the central nervous system responsible for influencing and controlling different organs, structures, and glands of the body. It is made up of two subdivisions: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PSNS). The sympathetic division is responsible for activating the body's "fight or flight" response, which helps the body work more efficiently in times of stress, while the parasympathetic division is primarily responsible for calming the body and restoring a homeostatic balance. The ANS is part of a large network of neurons and nerve fibers, which are interconnected to nerve cells in the brain and spinal cord. This network works together to control different organs and regulate bodily processes such as digestion, blood pressure, respiration, temperature, and heart rate. The ANS is capable of operating without conscious thought, such as when the body automatically regulates its breathing while sleeping. It is also responsible for triggering and controlling the body's involuntary responses to emotions or physical stimulus. The ANS is controlled by neurotransmitters which act as chemical messengers that travel between neurons and are responsible for carrying impulses through the nervous system. The neurotransmitters that influence the ANS are acetylcholine, adrenaline, noradrenaline, and serotonin. When these neurotransmitters are released by the ANS, they cause changes in the body such as an increased heart rate, perspiration, and respiration. In summary, the Autonomic Nervous System is an essential part of the body responsible for influencing and controlling the organs and glands, thereby maintaining homeostasis. Its subdivisions, the SNS and PSNS, work together to trigger involuntary responses as well as calming the body in response to physical and emotional stimulus. It is driven by four primary neurotransmitters which help regulate the body’s functions and preserve a consistent physiological environment.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States